| Mary Ellen Frazier, Psy.d. P.a. | |
|
834 Anchor Rode Dr Naples FL 34103-2739 | |
| (239) 643-9889 | |
| (239) 643-7074 |
| Full Name | Mary Ellen Frazier, Psy.d. P.a. |
|---|---|
| Speciality | Psychologist |
| Location | 834 Anchor Rode Dr, Naples, Florida |
| Authorized Official Name and Position | Mary Ellen Frazier (OWNER) |
| Authorized Official Contact | 2396439889 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Ellen Frazier, Psy.d. P.a. 834 Anchor Rode Dr Naples FL 34103-2739 Ph: (239) 643-9889 | Mary Ellen Frazier, Psy.d. P.a. 834 Anchor Rode Dr Naples FL 34103-2739 Ph: (239) 643-9889 |
| NPI Number | 1417254954 |
|---|---|
| Provider Enumeration Date | 02/18/2011 |
| Last Update Date | 02/18/2011 |
| Medicare PECOS PAC ID | 2163606443 |
|---|---|
| Medicare Enrollment ID | O20110411000761 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study, which show the significant improvement of overall sleep quality and marked improvement in Restless Legs Syndrome (RLS) experienced by patients after four months of daily home hemodialysis therapy with the NxStage System One™.
The new numbers are expected to get a skeptical reception from Virginia's House Appropriations Committee. Virginia health officials will face a skeptical House Appropriations Committee today over a new analysis that shows $1 billion in savings to the state over nine years from expanding its Medicaid program.
Senate Majority Leader Harry Reid last night unveiled a health care bill which includes pro-abortion language. The bill's language mirrors the Capps Amendment from the House debate - it allows the public option to include abortion coverage and provides federal subsidies for private plans which cover abortion.
An old Indian spice and a dye whose cousin makes sports drinks blue are pointing scientists toward better treatment of traumatic brain injuries.
Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417254954 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY3803 (Florida) | Primary |
| Provider Name | Mary Ellen Frazier |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1972554640 PECOS PAC ID: 1052595337 Enrollment ID: I20110421000492 |
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study, which show the significant improvement of overall sleep quality and marked improvement in Restless Legs Syndrome (RLS) experienced by patients after four months of daily home hemodialysis therapy with the NxStage System One™.
The new numbers are expected to get a skeptical reception from Virginia's House Appropriations Committee. Virginia health officials will face a skeptical House Appropriations Committee today over a new analysis that shows $1 billion in savings to the state over nine years from expanding its Medicaid program.
Senate Majority Leader Harry Reid last night unveiled a health care bill which includes pro-abortion language. The bill's language mirrors the Capps Amendment from the House debate - it allows the public option to include abortion coverage and provides federal subsidies for private plans which cover abortion.
An old Indian spice and a dye whose cousin makes sports drinks blue are pointing scientists toward better treatment of traumatic brain injuries.
Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.
› Verified 8 days ago
News Archive
NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study, which show the significant improvement of overall sleep quality and marked improvement in Restless Legs Syndrome (RLS) experienced by patients after four months of daily home hemodialysis therapy with the NxStage System One™.
The new numbers are expected to get a skeptical reception from Virginia's House Appropriations Committee. Virginia health officials will face a skeptical House Appropriations Committee today over a new analysis that shows $1 billion in savings to the state over nine years from expanding its Medicaid program.
Senate Majority Leader Harry Reid last night unveiled a health care bill which includes pro-abortion language. The bill's language mirrors the Capps Amendment from the House debate - it allows the public option to include abortion coverage and provides federal subsidies for private plans which cover abortion.
An old Indian spice and a dye whose cousin makes sports drinks blue are pointing scientists toward better treatment of traumatic brain injuries.
Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.
› Verified 8 days ago
Fresh Start Private Florida Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1415 Panther Ln, Naples, FL 34109 Phone: 239-591-6240 | |
Mindful Solutions Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4532 Tamiami Trl E Ste 302, Naples, FL 34112 Phone: 239-307-8038 | |
Psychotherapy Sw Fl Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 810 Anchor Rode Dr, Naples, FL 34103 Phone: 239-247-4231 | |
Little World Aba Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 708 Goodlette-frank Rd N Ste 326, Naples, FL 34102 Phone: 239-200-2405 | |
Dnt Institute Incorporated Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1750 Sw Health Pkwy, Naples, FL 34109 Phone: 239-566-7717 | |
Nami Of Collier County Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5020 Tamiami Trl N, Suite 110, Naples, FL 34103 Phone: 239-434-6726 | |
Behavioral Tender Care Corp Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 300 5th Ave S Ste 203d, Naples, FL 34102 Phone: 786-734-0684 |